Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
SMN1
Name:
survival of motor neuron 1 telomeric
Location:
05q13.2
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT00485511 | A Trial of Hydroxyurea in Spinal Muscular Atrophy | View | |
| NCT03837184 | Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies | View | |
| NCT01671384 | Valproate and Levocarnitine in Children With Spinal Muscular Atrophy | View | |
| NCT02122952 | Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 | View | |
| NCT02550691 | Identification of a Biomarker Associated With Cis-duplication of the SMN1 Gene | View | |
| NCT01059240 | SMN Copy Number Distribution in Mali West Africa | View | |
| NCT05760209 | SMN Circular RNAs as Potential New Targets and Biomarkers for SMA | View | |
| NCT05481164 | Newborn Screening for Spinal Muscular Atrophy | View | |
| NCT05544994 | The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy | View | |
| NCT00155168 | Quantitative Analysis of SMN1 and SMN2 Gene Based on DHPLC System | View | |
| NCT04576494 | Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults SMA Type 2 or 3 Forms | View | |
| NCT04851873 | Safety and Efficacy of Intravenous OAV101 AVXS-101 in Pediatric Patients With Spinal Muscular Atrophy SMA | View | |
| NCT01476462 | Second Malignant Neoplasms After Childhood ALL Therapy | View | |
| NCT02941328 | SPACE Trial Pyridostigmine vs Placebo in SMA Types 2 3 and 4 | View | |
| NCT05237544 | Newborn Screening for Spinal Muscular Atrophy SMA - a Proof of Principle Study Using Anonymised Blood Spots | View | |
| NCT03381729 | Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy | View | |
| NCT03461289 | Single-Dose Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1 | View | |
| NCT05475691 | Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin America | View | |
| NCT02466529 | Natural History of Spinal Muscular Atrophy Type 1 in Taiwan | View | |
| NCT05614531 | Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1 | View | |
| NCT04292574 | UK SMA Patient Registry | View | |
| NCT03217578 | Neonatal Spinal Muscular Atrophy SMA Screening | View | |
| NCT06147414 | Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders | View | |
| NCT06310421 | Spinal Muscular Atrophy Neonatal Screening Program | View | |
| NCT05335876 | Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials | View | |
| NCT04174157 | Registry of Patients With a Diagnosis of Spinal Muscular Atrophy SMA | View | |
| NCT06562283 | Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy | View | |
| NCT05073133 | Safety and Efficacy of Intravenous OAV101 AVXS-101 in Pediatric Patients With Spinal Muscular Atrophy SMA OFELIA | View | |
| NCT04317196 | Association of Copy Number Variations in the SMN Genes With Acute Kidney Injury After Heart Surgery | View | |
| NCT04404764 | Characterization of the Clinical-epidemiological Profile of Patients With SMA5q Types II and III Observational Study | View | |
| NCT05366465 | Quality of Life and Participation of the Adult With Spinal Muscular Atrophy in France | View | |
| NCT00061607 | Measuring Levels of SMN in Blood Samples of SMA Patients | View | |
| NCT02123186 | Newborn Screening for Spinal Muscular Atrophy | View | |
| NCT02855112 | Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients | View |